Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data

British Journal of Cancer

Volumn 95, Issue 7, 2006, Pages 835-840

  Kotz B S ^a,c   Croft, S ^a   Ferry, D R ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Delay; Oesophageal cancer; Prognosis; Surgical resection; Timing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DATA ANALYSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL TIME; TIME SERIES ANALYSIS;

AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33749348824     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603333     Document Type: Article

References (19)

1. Butsch J, Christein J, Millikan K (2002) Prognostic factors relating to esophageal cancer. Minerva Chir 57: 789-794
2. Clark P (2001) Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: and updated analysis of a randomised controlled trial conducted by the UK Medical Research Council upper GI Tract Cancer Group. ASCO Annu Meet Abstract No: 502
3. Dexter S, Sue-Ling S, McMahon M, Quirke P, Mapstone N, Martin I (2001) Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 48: 667-670
4. Frenken M (2001) Best palliation in esophageal cancer: surgery, stenting, radiation, or what? Dis Esophagus 14: 120-123
5. Gilbert F, Park K, Thompson A (2002) Scottish audit of gastric and oesophageal cancer. Report 1997-2000. A prospective audit. Edinburgh: Scottish Audit of Gastric and Oesophageal Cancer Steering Group (www.show.scot.nhs.uk/ crag)
6. Gillison E, Powell J, McConkey C, Spychal R (2002) Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg 89: 344-348
7. Greene F, Balch C, Fleming I, Fritz A, Haller D, Morrow M, Page D (2002) AJCC Cancer Staging Manual. Springer Verlag: New York
8. Hofstetter W, Swisher S, Correa A (2002) Treatment outcomes of resected esophageal cancer. Ann Surg 236: 376-385
9. Ibrahim N (2000) ACP Best Practice No. 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. J Clin Pathol 53: 89-94
10. Kelson D, Ginsberg R, Pajak T, Sheahan D, Gunderson L, Mortimer J, Estes N, Haller D, Ajani J, Kocha W, Minsky B, Roth J (1998) Chemotherapy followed by surgery compared to surgery alone for localized oesophageal cancer: a randomised controlled trial. N Engl J Med 339: 1979-1984
11. Lieberman M, Shriver C, Bleckner S, Burt M (1995) Carcinome of the esophagus: prognostic significance of histological type. J Thorac Cardiovasc Surg 109: 130-139
12. Martin I, Young S, Sue-Ling H, Johnston D (1997) Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 314: 467
13. McCulloch P, Ward J, Tekkis P (2003) Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327: 1192-1196
14. O'Connell J, Maggard M, Lui J, Etzioni D, Ko C (2004) A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? J Surg Res 121: 214-221
15. Medical Research Council Oesophageal Working Party (2002) Surgery with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727-1733
16. Richel D, Vervenne W (2004) Systemic treatment for oesophageal cancer. Eur J Gastroenterol Hepatol 16: 249-254
17. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluoruracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20: 1996-2004
18. Rothwell J, Feehan E, Reid I, Walsh T, Hennessy T (1997) Delay in treatment for oesophageal cancer. Br J Surg 84: 690-693
19. Sobin L, Wittekind C (2002) TNM Classification of Malignant Tumours. John Wiley & Sons: Hoboken, New Jersey